title: Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular system.
authors.affiliation: Department of Pharmacology, University of Amsterdam, Amsterdam, the Netherlands.
authors.forename: Maurits M
authors.initials: MM
authors.lastname: Barendrecht
authors.forename: Richard P
authors.initials: RP
authors.lastname: Koopmans
authors.forename: Jean J M C H
authors.initials: JJ
authors.lastname: de la Rosette
authors.forename: Martin C
authors.initials: MC
authors.lastname: Michel
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000517:prevention & control; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D010726:Phosphodiesterase Inhibitors